首页 | 本学科首页   官方微博 | 高级检索  
检索        

尿激酶溶栓治疗急性心肌梗死临床观察
引用本文:李芳芳,唐其柱.尿激酶溶栓治疗急性心肌梗死临床观察[J].医药论坛杂志,2011(7):1-2,6.
作者姓名:李芳芳  唐其柱
作者单位:武汉大学人民医院心内科;
摘    要:目的观察急性心肌梗死(AM I)患者尿激酶溶栓治疗的疗效、安全性及预后。方法选择符合溶栓治疗适应证、无溶栓治疗禁忌证急性心肌梗死(AM I)患者46例作为观察组,另选取30例有溶栓禁忌或不同意进行溶栓治疗的急性心肌梗死患者作为对照组。对两组疗效进行比较,对其再通情况和治疗后并发症、病死率进行比较分析。结果观察组在6h内和6~12h内以及总的再通率均高于对照组,差异有统计学意义(P<0.05);对照组的病死率、并发症均高于观察组,差异有统计学意义(P<0.05)。结论尿激酶溶栓治疗急性心肌梗死可以显著改善患者的预后,提高血管的再通率,减少病死率和并发症,是一种安全有效的再灌注疗法。

关 键 词:尿激酶溶栓  急性心肌梗死  临床观察

Observation of thrombolytic therapy with urokinase in patients with acute myocardial infarction
LI Fang-fang,TANG Qi-zhu People's Hospital of Wuhan University,Wuhan ,China.Observation of thrombolytic therapy with urokinase in patients with acute myocardial infarction[J].Journal of Medical Forum,2011(7):1-2,6.
Authors:LI Fang-fang  TANG Qi-zhu People's Hospital of Wuhan University  Wuhan  China
Institution:LI Fang-fang,TANG Qi-zhu People's Hospital of Wuhan University,Wuhan 430060,China
Abstract:Objective To investigate the efficacy,safety and prognosis of thrombolytic therapy with urokinase in patients with acute myocardial infarction(AMI).Methods AMI patients without contraindication for thrombolytic therapy were divided into observation group(n=46),while those who had thrombolytic contraindications or refused thrombolytic therapy were divided into control group(n=30).The recanalization,complications and mortalitiy after treatment of observation group were compared with that of control group.Resu...
Keywords:Urokinase  Acute myocardial infarction  Clinical observation  
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号